Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans 19 December
KEYTRUDA® Plus Padcev® Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery 17 December
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR in Adults with Pulmonary Arterial Hypertension 12 December
